Delpharm Group selected for large-scale production of firibastat tablets Delpharm Group selected for large-scale production of firibastat tablets Read the press realease Previous Post (p) Quantum Genomics to give an exclusive license for firibastat in Greece Next Post (n) Quantum Genomics launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension